Cyclic GMP-dependent pathways protect differentiated oligodendrocytes from multiple types of injury

Neurochemical Research

Volumn 32, Issue 2, 2007, Pages 321-329

  Benjamins, Joyce A ^a   Nedelkoska, Liljana ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cell death; Cyclic GMP; Kainate; Oligodendrocyte; Protein kinase G

Indexed keywords

8 BROMO CYCLIC AMP; 8 BROMO CYCLIC GMP; BONGKREKIC ACID; CALCIUM; CASPASE; CYCLIC GMP DEPENDENT PROTEIN KINASE; CYCLOSPORIN A; KAINIC ACID; NITRIC OXIDE; STAUROSPORINE; THAPSIGARGIN;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CELL DAMAGE; CELL DEATH; CELL DIFFERENTIATION; CELL PROTECTION; CONTROLLED STUDY; MOUSE; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; RAT;

8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; ANIMALS; BONGKREKIC ACID; CELL DEATH; CELL DIFFERENTIATION; CELLS, CULTURED; CYCLIC GMP; CYCLIC GMP-DEPENDENT PROTEIN KINASES; CYCLOSPORINE; KAINIC ACID; MICE; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; NITRIC OXIDE; NITROSO COMPOUNDS; OLIGODENDROGLIA; RATS; S-NITROSO-N-ACETYLPENICILLAMINE; SIGNAL TRANSDUCTION; STAUROSPORINE; THAPSIGARGIN;

MURINAE;

EID: 33846914456     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-006-9187-7     Document Type: Article

References (46)

1. Yoshioka A, Yamaya Y, Saiki S, Kanemoto M, Hirose G, Pleasure D (2000) Cyclic GMP/cyclic GMP-dependent protein kinase system prevents excitotoxicity in an immortalized oligodendroglial cell line. J Neurochem 74:633-640
2. Takuma K, Phuagphong P, Lee E, Mori K, Baba A, Matsuda T (2001) Anti-apoptotic effect of cGMP in cultured astrocytes: inhibition by cGMP-dependent protein kinase of mitochondrial permeable transition pore. J Biol Chem 76:48093-48099
3. Fiscus RR (2002) Involvement of cyclic GMP and protein kinase G in the regulation of apoptosis and survival in neural cells. Neurosignals 11:175-190 Review
4. Benjamins JA, Nedelkoska L, George (2003) Protection of mature oligodendrocytes by inhibitors of caspases and calpains. Neurochem Res 28:143-152
5. Boullerne AI, Nedelkoska L, Benjamins JA (2001) Role of calcium in nitric oxide- induced cytotoxicity in oligodendrocytes: EGTA protects mouse oligodendrocytes. J Neurosci Res 63:124-135
6. Dyer CA, Benjamins JA (1990) Glycolipids and transmembrane signaling: antibodies to galactocerebroside cause an influx of calcium in oligodendrocytes. J Cell Biol 111:625-633
7. Benjamins JA, Nedelkoska L (1996) Release of intracellular calcium stores leads to retraction of membrane sheets and cell death in mature mouse oligodendrocytes. Neurochem Res 21:471-479
8. McCarthy KD, de Vellis J (1980) Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol 85:890-902
9. Bottenstein JE (1986) Growth requirements in vitro of oligodendrocyte cell lines and neonatal rat brain oligodendrocytes. Proc Natl Acad Sci USA 83:1955-1959
10. Benjamins JA, Nedelkoska L (1994) Maintenance of membrane sheets by cultured oligodendrocytes requires continuous microtubule turnover and Golgi transport. Neurochem Res 19:631-639
11. Brand-Schieber E, Werner P (2003) (±)Alpha-amino-3-hydroxy-5- methylisoxazole-4- propionic acid and kainate receptor subunit expression in mouse versus rat spinal cord white matter: similarities in astrocytes but differences in oligodendrocytes. Neurosci Lett 345:126-130
12. Rosenberg PA, Li Y, Ali S, Altiok N, Back SA, Volpe JJ (1999) Intracellular redox state determines whether nitric oxide is toxic or protective to rat oligodendrocytes in culture. J Neurochem 73:476-484
13. Boullerne AI, Benjamins JA (2006) Nitric oxide synthase expression and nitric oxide toxicity in oligodendrocytes. Antioxidants and Redox Signaling 8:967-980
14. Wang X, Robinson PJ (1997) Cyclic GMP-dependent protein kinase and cellular signaling in the nervous system. J Neurochem 68:443-456 Review
15. Okada D (1992) Two pathways of cyclic GMP production through glutamate receptor-mediated nitric oxide synthesis. J Neurochem 59:1203-1210
16. Fedele E, Raiteri M (1999) In vivo studies of the cerebral glutamate receptor/NO/cGMP pathway. Prog Neurobiol 58:89-120 Review
17. Kim YM, Chung HT, Kim SS, Han JA, Yoo YM, Kim KM, Lee GH, Yun HY, Green A, Li J, Simmons RL, Billiar TR (1999) Nitric oxide protects PC12 cells from serum deprivation-induced apoptosis by cGMP-dependent inhibition of caspase signaling. J Neurosci 19:6740-6747
18. Ha KS, Kim YM, Kwon YG, Bai SK, Nam WD, Yoo YM, Kim PK, Chung HT, Billiar TR, Kim YM (2003) Nitric oxide prevents 6-hydroxydopamine-induced apoptosis in PC12 cells through cGMP-dependent PI3 kinase/Akt activation. Nitric oxide prevents 6-hydroxydopamine-induced apoptosis in PC12 cells through cGMP-dependent PI3-kinase/Akt activation. FASEB J 17:1036-1047
19. 2+ pump ATPase of vascular smooth muscle via phosphorylation of a 240-kDa protein. J Biol Chem 266:19819-19825
20. Baltrons MA, Garcia A (2001) The nitric oxide/cyclic GMP system in astroglial cells. Prog Brain Res 132:325-337 Review
21. Schubert P, Morino T, Miyazaki H, Ogata T, Nakamura Y, Marchini C, Ferroni S (2000) Cascading glia reactions: a common pathomechanism and its differentiated control by cyclic nucleotide signaling. Ann NY Acad Sci 903:24-33
22. Hofmann F (2005) The biology of cyclic GMP-dependent protein kinases. J Biol Chem 280:1-4 Review
23. Feil R, Hofmann F, Kleppisch T (2005) Function of cGMP-dependent protein kinases in the nervous system. Rev Neurosci 16:23-41 Review
24. Gamm DM, Francis SH, Angelotti TP, Corbin JD, Uhler MD (1995) The type II isoform of cGMP-dependent protein kinase is dimeric and possesses regulatory and catalytic properties distinct from the type I isoforms. J Biol Chem 270:27380-27388
25. Bertrand R, Solary E, O'Connor P, Kohn KW, Pommier Y (1994) Induction of a common pathway of apoptosis by staurosporine. Exp Cell Res 211:314-321
26. Tamaoki T, Nomoto H, Takahashi I, Kato Y, Morimoto M, Tomita F (1986) Staurosporine, a potent inhibitor of phospholipid/ Ca++dependent protein kinase. Biochem Biophys Res Commun 13:397-402
27. Ruegg UT, Burgess GM (1989) Staurosporine, K-252 and UCN-01: potent but nonspecific inhibitors of protein kinases. Trends Pharmacol Sci 10:218-220 Review
28. Herbert JM, Seban E, Maffrand JP (1990) Characterization of specific binding sites for [3H]-staurosporine on various protein kinases. Biochem Biophys Res Commun 171:189-195
29. Oka A, Belliveau MJ, Rosenberg PA, Volpe JJ (1999) Vulnerability of oligodendroglia to glutamate: pharmacology, mechanisms, and prevention. J. Neurosci 13:1441-1453
30. Deng W, Rosenberg PA, Volpe JJ, Jensen FE (2003) Calcium-permeable AMPA/kainate receptors mediate toxicity and preconditioning by oxygen-glucose deprivation in oligodendrocyte precursors. Proc Natl Acad Sci USA 100:6801-6806
31. Rosenberg PA, Dai W, Gan XD, Ali S, Fu J, Back SA, Sanchez RM, Segal MM, Follett PL, Jensen FE, Volpe JJ (2003) Mature myelin basic protein-expressing oligodendrocytes are insensitive to kainate toxicity. J Neurosci Res 71:237-245
32. Yoshioka A, Hardy M, Younkin DP, Grinspan JB, Stern JL, Pleasure D (1995) Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptors mediate excitotoxicity in the oligodendroglial lineage. J Neurochem 64:2442-2448
33. Rosin C, Bates TE, Skaper SD (2004) Excitatory amino acid induced oligodendrocyte cell death in vitro: receptor-dependent and -independent mechanisms. J Neurochem 90:1173-1185
34. Baud O, Li J, Zhang Y, Neve RL, Volpe JJ, Rosenberg PA (2004) Nitric oxide- induced cell death in developing oligodendrocytes is associated with mitochondrial dysfunction and apoptosis-inducing factor translocation. Eur J Neurosci 20:1713-1726
35. Tanaka J, Markerink-van Ittersum M, Steinbusch HW, De Vente J (1997) Nitric oxide- mediated cGMP synthesis in oligodendrocytes in the developing rat brain. Glia 19:286-297
36. Grabow M, Chakraborty G, Ledeen RW (1996) Characterization of guanylyl cyclase in purified myelin. Neurochem Res 21:457-462
37. Thippeswamy T, McKay JS, Morris R, Quinn J, Wong LF, Murphy D (2005) Glial- mediated neuroprotection: evidence for the protective role of the NO-cGMP pathway via neuronglial communication in the peripheral nervous system. Glia 49:197-210
38. Buskila Y, Farkash S, Hershfinkel M, Amitai Y (2005) Rapid and reactive nitric oxide production by astrocytes in mouse neocortical slices. Glia 52:169-176
39. 2+ signals in oligodendrocyte progenitors. Cell Calcium 26:121-130
40. Ebner S, Dunbar M, McKinnon RD (2000) Distinct roles for PI3K in proliferation and survival. J Neurochem Res 62:336-345
41. Cui Q, So KF (2004) Involvement of cAMP in neuronal survival and axonal regeneration. Anat Sci Int 79:209-212 Review
42. Palacios N, Sanchez-Franco F, Fernandez M, Sanchez I, Cacicedo L (2005) Intracellular oligodendrocyte development: modulation by cyclic AMP. J Neurochem 95:1091-1107
43. Flores AI, Mallon BS, Matsui T, Ogawa W, Rosenzweig A, Okamoto T, Macklin WB (2000) Akt-mediated survival of oligodendrocytes induced by neuregulins. J Neurosci 20:7622-7630
44. Cui QL, Fogle E, Almazan G (2006) Muscarinic acetylcholine receptors mediate oligodendrocyte progenitor survival through Src-like tyrosine kinases and PI3K/Akt pathways. Neurochem Int 48:383-393
45. Zaka M, Rafi MA, Rao HZ, Luzi P, Wenger DA (2005) Insulin-like growth factor-1 provides protection against psychosine-induced apoptosis in cultured mouse oligodendrocyte progenitor cells using primarily the PI3K/Akt pathway. Mol Cell Neurosci 30:398-407
46. Yoshioka A, Shimizu Y, Hirose G, Kitasato H, Pleasure D (1998) Cyclic AMP-elevating agents prevent oligodendroglial excitotoxicity. J Neurochem 70:2416-2423